Krystal Biotech, Inc. (KRYS) › Total AssetsKrystal Biotech, Inc. (KRYS) — Total AssetsAnnual figures by fiscal year, from SEC filings.2016: $2.18M2017: $50.11M2018: $116.12M2019: $209.02M2020: $310.84M2021: $626.29M2022: $558.45M2023: $818.36M2024: $1.06B2025: $1.33B$1.33B2016Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$1.33B+26.3%2024$1.06B+29.0%2023$818.36M+46.5%2022$558.45M-10.8%2021$626.29M+101.5%2020$310.84M+48.7%2019$209.02M+80.0%2018$116.12M+131.7%2017$50.11M+2196.7%2016$2.18M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share